APA (7th ed.) Citation

DL, C., JA, V., T, K., M, P., A, L., M, G., . . . A, V. (2025). Use of the IgG degrader imlifidase for a poorly desensitized patient undergoing haematopoietic stem cell transplantation with donor-specific antibodies. British journal of haematology, 206(3), 1004. https://doi.org/10.1111/bjh.20004

Chicago Style (17th ed.) Citation

DL, Cooper, et al. "Use of the IgG Degrader Imlifidase for a Poorly Desensitized Patient Undergoing Haematopoietic Stem Cell Transplantation with Donor-specific Antibodies." British Journal of Haematology 206, no. 3 (2025): 1004. https://doi.org/10.1111/bjh.20004.

MLA (9th ed.) Citation

DL, Cooper, et al. "Use of the IgG Degrader Imlifidase for a Poorly Desensitized Patient Undergoing Haematopoietic Stem Cell Transplantation with Donor-specific Antibodies." British Journal of Haematology, vol. 206, no. 3, 2025, p. 1004, https://doi.org/10.1111/bjh.20004.